These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 11950001)

  • 1. NSAID toxicity: where are we and how do we go forward?
    Hawkey CJ
    J Rheumatol; 2002 Apr; 29(4):650-2. PubMed ID: 11950001
    [No Abstract]   [Full Text] [Related]  

  • 2. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
    Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
    Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controversies in COX-2 selective inhibition.
    Simon LS; Smolen JS; Abramson SB; Appel G; Bombardier C; Brater DC; Breedveld FC; Brune K; Burmester GR; Crofford LJ; Dougados M; DuBois RN; Fitzgerald GA; Frishman W; García Rodríguez LA; Hochberg MC; Kalden JR; Laine L; Langman MJ; Prescott SM; van de Putte LB; Whelton A; White WB; Willaims GH
    J Rheumatol; 2002 Jul; 29(7):1501-10. PubMed ID: 12136912
    [No Abstract]   [Full Text] [Related]  

  • 4. [Undesired effects of NSAIDS and coxibs].
    Fauler J
    MMW Fortschr Med; 2005 Aug; 147(31-32):31-5. PubMed ID: 16128194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Do selective COX-2-inhibitors increase the risk of myocardial infarction?].
    Otterstad JE
    Tidsskr Nor Laegeforen; 2003 Dec; 123(23):3434-5. PubMed ID: 14713991
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacia and Pfizer on the CLASS trial: criticism doesn't give a fair picture of the results].
    Andersson T; Frösing R
    Lakartidningen; 2002 Oct; 99(41):4086. PubMed ID: 12451957
    [No Abstract]   [Full Text] [Related]  

  • 7. [Can we treat with modern antirheumatics? Costs of NSAID treatment].
    Bolten WW
    Pharm Unserer Zeit; 2002; 31(2):206-15. PubMed ID: 11977457
    [No Abstract]   [Full Text] [Related]  

  • 8. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 2000 Jul; 42(1082):57-64. PubMed ID: 10887424
    [No Abstract]   [Full Text] [Related]  

  • 9. [Excess mortality from cardiovascular disease in patients with rheumatoid arthritis--NSAID a possible cause?].
    Pind R
    Ugeskr Laeger; 2011 Mar; 173(11):837; author reply 837. PubMed ID: 21520672
    [No Abstract]   [Full Text] [Related]  

  • 10. Serious gastrointestinal events from low dose analgesic use.
    Tarone RE; Lipworth L; McLaughlin JK
    J Rheumatol; 2004 May; 31(5):1008-9; author reply 1010-1. PubMed ID: 15124269
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adverse effects of non-steroidal antirheumatic drugs with special reference to the gastrointestinal tract].
    Hackenthal E
    Z Rheumatol; 1987; 46 Suppl 1():83-8. PubMed ID: 3439373
    [No Abstract]   [Full Text] [Related]  

  • 12. Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use.
    Laine L; Connors LG; Reicin A; Hawkey CJ; Burgos-Vargas R; Schnitzer TJ; Yu Q; Bombardier C
    Gastroenterology; 2003 Feb; 124(2):288-92. PubMed ID: 12557133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recommendations for treatment with nonsteroidal anti-inflammatory drugs].
    Bolten WW
    MMW Fortschr Med; 2005 Aug; 147(31-32):24-7. PubMed ID: 16128192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of small bowel injury in patients with rheumatoid arthritis by capsule endoscopy: effects of anti-rheumatoid arthritis drugs.
    Sugimori S; Watanabe T; Tabuchi M; Kameda N; Machida H; Okazaki H; Tanigawa T; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Oshitani N; Koike T; Higuchi K; Arakawa T
    Digestion; 2008; 78(4):208-13. PubMed ID: 19142000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis.
    Maetzel A; Krahn M; Naglie G
    Arthritis Rheum; 2003 Jun; 49(3):283-92. PubMed ID: 12794781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal side-effects of traditional non-steroidal anti-inflammatory drugs and new formulations.
    Lazzaroni M; Bianchi Porro G
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 2():48-58. PubMed ID: 15335413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NSAID gastropathy: state of the art.
    Cervini C; Grassi W; De Angelis R
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():1-5. PubMed ID: 9032572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Financial interests characterize published reports on coxiber. Whom can we rely on?].
    Håkansson J
    Lakartidningen; 2002 Oct; 99(40):3930-1. PubMed ID: 12422746
    [No Abstract]   [Full Text] [Related]  

  • 19. [Selective COX-2 non-steroidal anti-inflammatory agents and gastrointestinal toxicity].
    Zaragoza A; Llorente MJ; García MM; Ramírez JJ; Lloret G; Machancoses A
    Rev Esp Enferm Dig; 2001 Dec; 93(12):819-20. PubMed ID: 11995364
    [No Abstract]   [Full Text] [Related]  

  • 20. [Gastrointestinal manifestations in rheumatoid arthritis].
    Tokuda M; Dobashi H
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():257-60. PubMed ID: 15799356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.